Bergsland KJ, Worcester EM, Coe FL. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol 305: F592-F599, 2013. First published May 29, 2013 doi:10.1152/ajprenal.00116.2013The most common metabolic abnormality found in calcium (Ca) kidney stone formers is idiopathic hypercalciuria (IH). Using endogenous lithium (Li) clearance, we previously showed that in IH, there is decreased proximal tubule sodium absorption, and increased delivery of Ca into the distal nephron. Distal Ca reabsorption may facilitate the formation of Randall's plaque (RP) by washdown of excess Ca through the vasa recta toward the papillary tip. Elevated Ca excretion leads to increased urinary supersaturation (SS) with respect to calcium oxalate (CaOx) and calcium phosphate (CaP), providing the driving force for stone growth on RP. Thiazide (TZ) diuretics reduce Ca excretion and prevent stone recurrence, but the mechanism in humans is unknown. We studied the effect of chronic TZ administration on renal mineral handling in four male IH patients using a fixed three meal day in the General Clinical Research Center. Each subject was studied twice: once before treatment and once after 4 -7 mo of daily chlorthalidone treatment. As expected, urine Ca fell with TZ, along with fraction of filtered Ca excreted. Fraction of filtered Li excreted also fell sharply with TZ, as did distal delivery of Ca. Unexpectedly, TZ lowered urine pH. Together with reduced urine Ca, this led to a marked fall in CaP SS, but not CaOx SS. Since CaOx stone formation begins with an initial CaP overlay on RP, by lowering urine pH and decreasing distal nephron Ca delivery, TZ might diminish stone risk both by reducing CaP SS, as well as slowing progression of RP. calcium oxalate; calcium phosphate; idiopathic hypercalciuria; kidney calculi; thiazide THE MOST COMMON METABOLIC abnormality found in calcium (Ca) stone formers is so-called idiopathic hypercalciuria (IH) (40). Patients with IH absorb more Ca from a given meal than normal people (N), but also have abnormally decreased renal tubule Ca reabsorption, so that they often excrete more Ca than they have absorbed, exhibit decreased bone density, and have a propensity for increased fractures (22, 42) . Elevated urine Ca excretion leads to increased urinary supersaturation (SS) with respect to both calcium oxalate (CaOx) and calcium phosphate (CaP), providing the driving force for kidney stone formation (36). In addition, urine Ca excretion is correlated with the amount of interstitial apatite deposits (called Randall's plaque) found on the surface of the renal papillae (19). These deposits are the attachment sites for most CaOx stones and appear to be critical for stone formation (14). A plausible mechanism by which increased Ca reaches the deep papillae is via washdown from reabsorption in the thick ascending limb; an increase in delivery of Ca to this site would tend to increase reabsorption and washdown into the papilla and potentially increase the formation of Randall's plaque (10).
THE MOST COMMON METABOLIC abnormality found in calcium (Ca) stone formers is so-called idiopathic hypercalciuria (IH) (40) . Patients with IH absorb more Ca from a given meal than normal people (N), but also have abnormally decreased renal tubule Ca reabsorption, so that they often excrete more Ca than they have absorbed, exhibit decreased bone density, and have a propensity for increased fractures (22, 42) . Elevated urine Ca excretion leads to increased urinary supersaturation (SS) with respect to both calcium oxalate (CaOx) and calcium phosphate (CaP), providing the driving force for kidney stone formation (36) . In addition, urine Ca excretion is correlated with the amount of interstitial apatite deposits (called Randall's plaque) found on the surface of the renal papillae (19) . These deposits are the attachment sites for most CaOx stones and appear to be critical for stone formation (14) . A plausible mechanism by which increased Ca reaches the deep papillae is via washdown from reabsorption in the thick ascending limb; an increase in delivery of Ca to this site would tend to increase reabsorption and washdown into the papilla and potentially increase the formation of Randall's plaque (10) .
Thiazide-type (TZ) diuretics are commonly used as a treatment for Ca stones. Three randomized, placebo-controlled trials have shown that use of a TZ-type drug (hydrochlorothiazide, chlorthalidone, or indapamide in one trial each) can significantly decrease the recurrence of stones compared with placebo over three years (4, 13, 20) . The effect of TZ to reduce stones appears due, at least in part, to their ability to decrease urine Ca excretion (33) .
The ability of TZ to lower urine Ca was noted soon after they came into use (21) , and balance studies have confirmed that although they decrease gut Ca absorption, they reduce renal Ca excretion more, and can lead to a positive Ca balance in both IH and N (12, 24) . The mechanism of chronic TZ hypocalciuria is unclear. In short-term studies, administration of TZ causes modest Na depletion, which is associated with a fall in urine Ca excretion; the hypocalciuria can be prevented by administration of sodium chloride (6, 7, 30, 32) . However, these studies have rarely included subjects with IH and usually were limited to a week or less in duration. Studies in animals suggest that increased proximal tubule sodium and Ca absorption is a likely mechanism for TZ hypocalciuria (28) , but not necessarily the only one (23) . Rodents exposed to TZ exhibit upregulation of the sodium-hydrogen exchanger, the sodiumchloride cotransporter, and several isoforms of the epithelial sodium channel (ENaC) (25) , and lithium (Li) clearance data indicate that proximal Na reabsorption increases with shortterm TZ administration (28) . However, TZ can prevent (23) or significantly blunt (17) the rise in Ca excretion seen when rodents receive sodium supplementation to prevent volume depletion during TZ administration, and upregulation of distal tubule Ca channel (TRPV5) and calbindin expression has been reported with administration of TZ in some (17, 23) , but not all (27) , studies. These data suggest that increased distal nephron Ca reabsorption may be an important mechanism for TZinduced hypocalciuria in some circumstances (17, 23) .
We set out to determine the mechanism by which chronic TZ administration leads to decreased urine Ca excretion in human stone formers with IH; if increased proximal tubule sodium and Ca reabsorption is at least some component of this phenomenon, then in addition to lowering the recurrence of stones, decreased Randall's plaque formation could be a second benefit of TZ treatment.
METHODS
Patients. Four male patients with IH were compared with 7 male age-matched N (Table 1) . IH was diagnosed by 24-h urine Ca excretion rates Ͼ140 mg Ca/g urine creatinine on an outpatient free choice diet (11) and exclusion of all systemic Ca disorders. Pretreatment daily Ca excretion of the four IH patients ranged from 206 to 292 mg Ca/g creatinine. Three of the four IH patients formed Ca stones, two CaOx, and one CaP. The fourth subject had bone disease ascribed to IH, and no stones. N had no personal history of stone disease. Before the study, no subject was taking medications that could affect stones or mineral metabolism such as TZs or other diuretic agents, vitamin D, or alkali supplements. This study was approved by the Institutional Review Board at the University of Chicago (protocol no. 12881A).
Protocol. Subjects were studied in the General Clinical Research Center over 14 h. Two 1-h fasting urine specimens were collected; then subjects ate three study meals, with hourly urine collections until 3 h after the last meal. Matching blood samples were collected hourly, and every half hour in the 2 h following meals, for a total of 21 samples. Finally, subjects collected their urine overnight (ϳ10-h) for a total of 15 urine samples. IH patients were studied on two different days, once before treatment and once after ϳ6 mo of taking chlorthalidone, 25 mg daily. The study diet consisted of three isocaloric meals composed of common foods, calculated to provide a total of 1,200 mg each of Ca and phosphorus and 2,000 mg sodium, over the course of the day. Subjects were stratified to one of three caloric levels (1,800, 2,100, or 2,400 kcal/day) on the basis of an estimate of individual needs. Water was provided ad libitum.
Laboratory methods. All urine and serum analytes were measured in our laboratory on a Beckman DxC 600 analyzer (1), with the following exceptions. Serum Ca was measured by atomic absorption on a Perkin Elmer AAnalyst 100 spectrometer (5). Serum and urine Li were measured using flame atomic emission spectroscopy (41) . Serum intact parathyroid hormone (PTH) and calcitriol were measured by LabCorp (Burlington, NC) using electrochemiluminescence immunoassay (Roche, Elecsys, Indianapolis, IN) and the DiaSorin radioimmunoassay, respectively. SS for CaOx and CaP were calculated using EQUIL 2 (38) . Serum samples were ultrafiltered using a 10-kDa MW cutoff membrane (Amicon Ultra-4, Millipore, Bedford, MA); Ca, magnesium (Mg), phosphorus (P), and creatinine were measured in serum ultrafiltrate (UF) on the Beckman analyzer as above.
Calculations. We have chosen to express all excretions per hour and all concentrations as molarities. Creatinine and Li clearances (CCr and CLi, respectively) were calculated conventionally: CCr ϭ (Ucr·volume)/UFcr (Eq. 1) and CLi ϭ (ULi·volume)/SLi (Eq. 2).
Filtered loads of Li, sodium (Na), Ca, Mg, and P are the products of CCr and serum Li and Na, and serum UF Ca, Mg, and P concentrations, respectively. Fractional excretions are ratios of excretions to filtered loads. Distal delivery (dDel) from proximal tubule of Ca or Na (dDel Ca or dDel Na) is the product of the relevant UF molarity ϫ CLi. Fraction of dDel excreted (FEdDelCa or FEdDelNa) is the ratio of urine excretion to dDel. Absolute distal reabsorption (ACaR or ANaR) is dDel Ϫ excretion. Net acid excretion was calculated as the sum of urine titratable acid ϩ ammonia Ϫ bicarbonate. Net GI absorption of metabolizable anion was calculated as the sum of urine (Na ϩ K ϩ Ca ϩ Mg) Ϫ (Cl ϩ Phos), where all are expressed in milliequivalents (29) .
Statistical analysis. Means and significance of differences of means between TZ and control periods within fasting or fed states were calculated by simple 2-way ANOVA. Comparison of TZ treatment results to normal male control results were conducted in a separate two-way ANOVA because we have already published differences between stone formers and controls in the absence of TZ, and the present work does not concern that comparison. Analyses used conventional software, Systat, version 13 (Systat Software, Chicago, IL).
RESULTS
For clarity of presentation, we have gathered all of our TZ vs. no TZ comparisons in one table (Table 2) , and all of our fasting vs. fed comparisons under no TZ and TZ conditions in a separate table (Table 4) . Table 2 presents mean differences between thiazide and no thiazide, as this is the manner in which the computations were actually performed. Table 4 presents the actual mean values for every measurement along with an estimate of variance (SE).
Sodium and potassium. Serum Li levels and filtered loads of Li both rose with TZ in fasting and fed states ( Table 2) and Li clearance and FELi fell ( Table 2 and Fig. 1 , bottom left). Although TZ reduced serum Na levels, distal Na delivery and distal Na reabsorption (Table 2) , urine Na excretion, filtered load (FLNa), and FENa were unaffected by the drug. Although reduced from pretreatment levels, Li clearance, FELi, distal Na delivery, and distal Na reabsorption during TZ treatment remained higher than in normal controls in the fed, but not the fasting state (Table 2 , columns 4 and 5). Serum K fell, as expected. Mean values for all parameters for IH and N before and during TZ treatment are detailed in Table 4 .
Calcium. Urine Ca excretion ( Fig. 1 , top left; Table 2 ) fell with TZ treatment in the fed state. The fraction of filtered Ca excreted (FECa) also fell both when fasting and with meals ( Fig. 1 , top right, Table 2 ). Filtered loads of Ca were unaltered even though serum Ca was increased by TZ in the fed state ( Table 2) . Because of stable filtered load and increased prox- imal tubule reabsorption, as evidenced by reduced FELi, distal delivery of Ca (Table 2 and Fig. 1 , bottom right) fell in both the fasting and fed state, even though serum Ca rose in the fed state ( Table 2) . As expected, given a fall in distal delivery, distal Ca reabsorption fell (Table 2 ), but in the fed state the fraction of distal Ca excreted actually rose significantly (Table 2) . Plasma PTH levels fell with TZ in the fasting and fed states (Table 2) and also fell with and without TZ in the fed compared with the fasting state (Table 4) . Urine cAMP/g urine creatinine did not change significantly (Table 2 ). Filtered loads of cAMP could not be measured. Taken together, TZ appears to increase proximal tubule reabsorption and reduce delivery of Ca to more distal sites, which could contribute to a fall in urine Ca. But the drug did not bring values in our patients to those of our normal men in the fed state (Table 2) . Distal Ca delivery and reabsorption, urine Ca excretion, and FECa all remained above normal.
Overnight and fasting, urine pH was lower with TZ than control (Fig. 2, top left) , but differences did not achieve significance (Table 3 ). In the fed state, the fall in pH with TZ (Fig. 2 , top middle) was significant ( Table 3) . Because of the fall in urine Ca and pH already noted, SS with respect to CaP fell markedly (Fig. 2, lower middle) in the fed state, to a statistically significant extent. The fall overnight is also dramatic but not significant, given only four patients (Fig. 2, lower  left) . In the fasted state, changes in CaP SS were minimal. CaOx SS also fell with TZ, but variably and without significance (Fig. 2, top and bottom right, Table 3 ). The fall was entirely due to the fall in urine Ca; urine volume was not affected by TZ (Table 3) Values are differences in means with 95% confidence intervals in parentheses. Columns 2 and 3 depict differences between IH subjects while taking thiazide and pretreatment, within fasting and fed states; columns 4 and 5 depict differences between IH subjects taking thiazide and normal subjects, within fasting and fed periods. Bold values indicate significant difference from 0, P Ͻ 0.05. S Li, S Na, S K, S Ca, S Phos, S Mg are serum Li, Na, potassium, calcium, phosphorus and magnesium, respectively. FLLi, FLNa and FLCa are filtered loads of Li, Na and calcium, respectively. U Na, U K, U Ca, U Li and U Mg are urine Na, potassium, calcium, lithium and magnesium excretions, respectively. C Li is Li clearance; FELi, FENa, FECa, FEMg and FEP are fractional excretions of Li, Na and calcium, magnesium, and phosphorus, respectively. dDelNa and dDelCa are distal delivery of Na and calcium, respectively. ANaR and ACaR are absolute distal reabsorption of Na and calcium, respectively. FEdDelNa and FEdDelCa are fraction of distal delivery excreted of Na or calcium, respectively. CCr, creatinine clearance rate; P PTH, plasma parathyroid hormone; UcAMP/Cr, urine cyclic AMP (M) per gram creatinine.
None of these six constituents changed significantly, but the individual changes (Ϫ2.27, 0.38, 0.09, and Ϫ0.17 for the cations, respectively, and Ϫ0.42 and 0.36 for the anions) yield the overall change of Ϫ1.91. Given the loss of 1.91 meq/h of anion and increase of NAE of 1.39, one might presume a small increase in net systemic acid delivery of 0.52 meq/h for the fed state although given the variability involved net acid balance might well be neutral.
Magnesium and phosphorus. TZ lowered serum Mg and raised fractional excretion of Mg in the fed period above both pretreatment values and values in normal males (Table 2) . TZ lowered serum P levels below normal controls in the fed state but increased it above the low values of the patients in the control periods. It did not affect fractional excretion of P (Table 2) or urine P excretion (not shown).
DISCUSSION
In this study, as in our prior work, subjects with IH have increased Li clearance at baseline, compared with controls, reflecting decreased proximal tubule reabsorption of Na (41) . Since Ca reabsorption at this site is passive and follows Na (16) , the delivery of both Na and Ca out of the proximal tubule is increased in men with IH compared with N. TZ decreased Li clearance and distal delivery of Na and Ca out of proximal tubule in IH (Table 2) , providing evidence that a significant mechanism for the hypocalciuric action of the drug is via increased proximal tubule reabsorption. Creatinine clearance, Ca filtered load, and urine Na excretion were not altered by chronic TZ treatment. A modest drop in intravascular volume has been shown to occur after initiation of TZ in other studies (7, 34) , after which subjects come into balance at this new modestly decreased weight, and Na excretion returns to baseline; presumably volume depletion occurred in our subjects as well ( Table 1) .
The effect of TZ on distal Ca delivery and fractional urine Ca excretion is present in both fasting and fed states; however, patients with IH still exhibit sensitivity to nutrient ingestion. TZ tends to normalize proximal tubule Na and Ca handling in IH, so that, at least in the fasting period, delivery of Na and Ca out of proximal tubule does not differ between control men and men with IH on TZ, nor does urine Ca excretion. During the fed period, absolute and fractional Ca excretion increases in both normal men and men with IH. However, in IH, unlike normal men, distal delivery of Na and Ca rises after feeding, even during TZ administration and exceeds that of normal men eating the same food. Thus, TZ may ameliorate, but not totally correct, the abnormalities of Na and Ca handling found in IH, which are expressed in decreased proximal tubule solute reabsorption, particularly after meals. A further implication of these data is that the increase in Ca excretion with meals in normal men is due to changes in Ca handling beyond the proximal tubule; in IH, the augmented delivery of Ca out of the proximal tubule may amplify this distal event. Alternatively, there may be additional abnormalities in distal Ca handling in IH, which cannot be detected in this study.
During the fed period, much of the increased Na and Ca delivered out of proximal tubule is eventually reabsorbed in the distal nephron, such that distal Na and Ca reabsorption in IH Table 2 ).
exceeds that of normal subjects (41) . The site of this reabsorption is not known, however, and for Ca, it may be located in either ascending limb or distal tubule. Our current data do not allow us to discriminate between these sites at present. However, probably because of decreased delivery, absolute distal Ca reabsorption in IH is significantly lower on TZ than at baseline, suggesting that there may be less Ca furnished to sites in the inner medulla, where Randall's plaque is formed. Future studies may be able to confirm whether TZ administration is able to decrease plaque formation in patients with IH.
We recognize that our calculations rely on the assumption that calcium reabsorption follows sodium reabsorption in proximal tubule. Whether or not this relationship is disrupted, in part, by active calcium transport in the S3 segment (31) , as has been demonstrated in perfused rabbit S3 segments, cannot be determined in humans at the present time. Likewise, under conditions of diuretic-induced volume contraction, lithium reabsorption in the distal nephron via ENaC-mediated transport may render interpretation of lithium clearance less certain as a marker of proximal tubule reabsorption (18, 35) . We calculated the urine Na/K molarity ratio as a gauge of such an effect and found the ratio fell with TZ in the fed period [Ϫ1.18 (Ϫ2.32, Ϫ0.05) P ϭ 0.037]. Given this finding, we must accept the possibility of an overestimate of the reduction of Li clearance with TZ; we cannot quantify its magnitude further.
Our data confirm those of other investigators, who have found a decrease in urine SS with respect to Ca salts in patients with IH treated with TZ. Woelfel et al. (39) measured SS only Table 3 ). Calcium phosphate (CaP) SS (bottom left and middle) also fell significantly in the fed period (bottom middle; Table 3 ). Changes in CaOx SS (right top and bottom) with thiazide treatment were variable and insignificant. for CaOx, and they found that it decreased significantly in four of seven patients treated with TZ for 3-4 mo. Borghi et al. (4) assessed SS for both CaOx and CaP at regular intervals during their placebo-controlled trial of indapamide, and they found significant decreases in both at 6 mo in the indapamide arms, which declined further by 12 mo. However, unlike other studies, we found a decrease in urine pH in IH patients while on chlorthalidone, which is significant during the fed period, and this has consequences for urine SS. Nicar et al. (26) found a slight fall in pH (5.97 Ϯ 0.49 vs. 5.84 Ϯ 0.49) with thiazide, but 24-h urine samples were used in a diet-controlled, but outpatient, setting; perhaps with a CRC design, this fall might have achieved significance. Although there is a trend to decreased urine SS with respect to both CaOx and CaP, only the drop in CaP SS during the fed period is significant among our patients. The fact that there is only one overnight urine sample per patient in each study phase limits the ability for changes to reach significance at that time period. Although decreases in both types of SS have importance for prevention of Ca stones, CaP may be of particular importance, as even for stones composed primarily of CaOx, the initiating phase is CaP (15) .
The fall of urine pH with TZ clearly reflects an increase of NAE, and this can be ascribed to a fall in GI organic anion absorption as calculated from the difference between the sum of the major nonmetabolizable cations and anions (29) . The numerically main reason for the fall in GI anion absorption, as calculated, is a fall in urine Na not balanced by a corresponding fall in urine chloride. Given the fixed diets used with TZ and control periods, we have to presume these changes could reflect effects of TZ on GI, as well as renal transport. As this is simply an observation during the course of our experiment, the present study cannot elucidate mechanisms further.
Several metabolic changes that were expected were noted during TZ treatment, such as modest decreases in serum Na, Mg, and K, and a rise in serum Ca that occurred during the fed period. Prior studies in which PTH was evaluated during TZ treatment of IH have shown conflicting results. In one study, no change was found in PTH in IH patients during TZ treatment compared with baseline (37) . However, in accordance with two other studies, we found a small, but significant, decrease in PTH related to TZ treatment (8, 9) . In our study, PTH was measured at multiple time points throughout the day, which may facilitate the detection of small, but potentially significant, changes in PTH related to TZ treatment. The drop may be the result of the modest rise in serum Ca that occurs during TZ treatment, although this rise is seen predominantly in the fed period, while PTH is significantly lower in both the fasting and fed states. The effect on distal Ca reabsorption from the decrease in PTH is unclear. Of note, vitamin D tended to fall in all four patients, but the difference was not significant (Table 1) .
Urine Mg does not increase during chronic TZ therapy, but because serum Mg and the filtered load of Mg decrease, the fractional excretion of Mg rose with TZ treatment and presumably led to the fall in serum Mg that we observed. This could reflect decreased reabsorption in either the thick ascending limb or in the distal nephron. Nijenhuis et al. (28) found that mice exposed to TZ had a decrease in the expression of the magnesium channel TRPM6 in the distal tubule. This could be one potential explanation for the relative decrease in magnesium reabsorption seen in our subjects. Our previous studies using endogenous Li clearance have shown that many patients with IH have decreased proximal tubule Na reabsorption and deliver increased Ca into the distal nephron where reabsorption, although increased, is inadequate to prevent hypercalciuria (41, 42) . This explanation for IH would also provide a mechanism for the initiation and growth of Randall's plaque, via increased delivery of Ca to the thick ascending limb and resultant loading of the medullary interstitium with the augmented Ca reabsorption that would result (10) . TZs should be an ideal treatment for this abnormality, by potentially normalizing Ca reabsorption in the proximal tubule. Since overgrowth on exposed plaque surface is the major way by which idiopathic CaOx stones form (15) , decreasing plaque formation may be a second mechanism by which TZs can prevent recurrent stones, in addition to lowering urine Ca.
Our study suggests that a main hypocalciuric effect of chronic TZ treatment in IH is increased proximal tubule reabsorption of Na and Ca, with consequent decrease in urine Ca excretion and urinary SS with respect to CaOx and CaP. This may have the additional effect of decreasing formation of Randall's plaque, which might provide additional protection from stone recurrence.
